Patrick J Zenner insider trades
Open-market stock purchases and sales by Patrick J Zenner, Director at Cartesian Therapeutics, Inc, from SEC Form 4 filings since May 4, 2010.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +257%.
Companies traded
- RNAC Cartesian Therapeutics, Inc: other filings, last Jan 2, 2026
- SELB Selecta Biosciences Inc: other filings, last Jan 2, 2023
- WST West Pharmaceutical Services Inc: 5 buys, 9 sales, last Mar 31, 2022
- ARQL Arqule Inc: 7 buys, last Jan 16, 2020
- PRX PAR Pharmaceutical Companies, Inc: other filings, last Sep 28, 2012
- GERN Geron Corp: other filings, last May 19, 2010